Investing Profile

Andrew Sinclair

InvestorVC
Partner, Portfolio Manager at Abingworth
Photo of Andrew Sinclair, Partner at Abingworth
cb
Abingworth Partner
$15.0M - $30.0M
$22.5M
2
$465M
CompanyStageDateRound SizeTotal Raised
Entact Bio
Series ADec 2022$81M
$81M
Co-investors: Owen Smith (4BIO Capital), Richard Gaster (venBio)
Soleno Therapeutics
Post Ipo EquityDec 2018$17M
$17M
Co-investors: Jack Schuler
Partner, Portfolio Manager Abingworth2008 - Present